Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

This document is a response to comments for MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (LCD DL38684). It records the comment period (09/29/2022–11/12/2022), the notice period start (06/29/2023), and the LCD effective date (08/13/2023); no specific coverage indications, exclusions, documentation requirements, or frequency limits are specified in this notice.